175 related articles for article (PubMed ID: 28092099)
1. Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells.
Fancy RM; Kim H; Zhou T; Zinn KR; Buchsbaum DJ; Song Y
J Cell Biochem; 2017 Aug; 118(8):2285-2294. PubMed ID: 28092099
[TBL] [Abstract][Full Text] [Related]
2. Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.
Yuan K; Yong S; Xu F; Zhou T; McDonald JM; Chen Y
Oncotarget; 2015 Sep; 6(28):25308-19. PubMed ID: 26320171
[TBL] [Abstract][Full Text] [Related]
3. Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells.
Fancy RM; Kim H; Napier T; Buchsbaum DJ; Zinn KR; Song Y
J Cell Biochem; 2018 Jul; 119(7):6216-6230. PubMed ID: 29663486
[TBL] [Abstract][Full Text] [Related]
4. Calmodulin binding to the Fas-mediated death-inducing signaling complex in cholangiocarcinoma cells.
Chen Y; Pawar P; Pan G; Ma L; Liu H; McDonald JM
J Cell Biochem; 2008 Feb; 103(3):788-99. PubMed ID: 17654480
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells: AN INTEGRATED EXPERIMENTAL AND COMPUTATIONAL STUDY.
Fancy RM; Wang L; Zeng Q; Wang H; Zhou T; Buchsbaum DJ; Song Y
J Biol Chem; 2016 Jun; 291(24):12862-12870. PubMed ID: 27129269
[TBL] [Abstract][Full Text] [Related]
6. TRAIL enhances quinacrine-mediated apoptosis in breast cancer cells through induction of autophagy via modulation of p21 and DR5 interactions.
Das S; Nayak A; Siddharth S; Nayak D; Narayan S; Kundu CN
Cell Oncol (Dordr); 2017 Dec; 40(6):593-607. PubMed ID: 28936683
[TBL] [Abstract][Full Text] [Related]
7. Structural Insight for Roles of DR5 Death Domain Mutations on Oligomerization of DR5 Death Domain-FADD Complex in the Death-Inducing Signaling Complex Formation: A Computational Study.
Yang H; Song Y
J Mol Model; 2016 Apr; 22(4):89. PubMed ID: 26995783
[TBL] [Abstract][Full Text] [Related]
8. 5-Fluorouracil signaling through a calcium-calmodulin-dependent pathway is required for p53 activation and apoptosis in colon carcinoma cells.
Can G; Akpinar B; Baran Y; Zhivotovsky B; Olsson M
Oncogene; 2013 Sep; 32(38):4529-38. PubMed ID: 23108402
[TBL] [Abstract][Full Text] [Related]
9. Modulation of TRAIL resistance in colon carcinoma cells: different contributions of DR4 and DR5.
van Geelen CM; Pennarun B; Le PT; de Vries EG; de Jong S
BMC Cancer; 2011 Jan; 11():39. PubMed ID: 21272366
[TBL] [Abstract][Full Text] [Related]
10. Trifluoperazine regulation of calmodulin binding to Fas: a computational study.
Pan D; Yan Q; Chen Y; McDonald JM; Song Y
Proteins; 2011 Aug; 79(8):2543-56. PubMed ID: 21656570
[TBL] [Abstract][Full Text] [Related]
11. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.
Das S; Tripathi N; Preet R; Siddharth S; Nayak A; Bharatam PV; Kundu CN
Oncotarget; 2017 Jan; 8(1):248-267. PubMed ID: 27542249
[TBL] [Abstract][Full Text] [Related]
12. Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer.
Pennarun B; Meijer A; de Vries EG; Kleibeuker JH; Kruyt F; de Jong S
Biochim Biophys Acta; 2010 Apr; 1805(2):123-40. PubMed ID: 19961901
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
[TBL] [Abstract][Full Text] [Related]
14. Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model.
Buchsbaum DJ; Zhou T; Grizzle WE; Oliver PG; Hammond CJ; Zhang S; Carpenter M; LoBuglio AF
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3731-41. PubMed ID: 14506165
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of B-Raf/MEK/ERK signaling suppresses DR5 expression and impairs response of cancer cells to DR5-mediated apoptosis and T cell-induced killing.
Oh YT; Deng J; Yue P; Owonikoko TK; Khuri FR; Sun SY
Oncogene; 2016 Jan; 35(4):459-67. PubMed ID: 25867065
[TBL] [Abstract][Full Text] [Related]
16. LY303511 amplifies TRAIL-induced apoptosis in tumor cells by enhancing DR5 oligomerization, DISC assembly, and mitochondrial permeabilization.
Poh TW; Huang S; Hirpara JL; Pervaiz S
Cell Death Differ; 2007 Oct; 14(10):1813-25. PubMed ID: 17585340
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5.
Li Y; Fan X; Goodwin CR; Laterra J; Xia S
BMC Cancer; 2008 Nov; 8():325. PubMed ID: 18992144
[TBL] [Abstract][Full Text] [Related]
18. Calmodulin binding to cellular FLICE-like inhibitory protein modulates Fas-induced signalling.
Pawar PS; Micoli KJ; Ding H; Cook WJ; Kappes JC; Chen Y; McDonald JM
Biochem J; 2008 Jun; 412(3):459-68. PubMed ID: 18257744
[TBL] [Abstract][Full Text] [Related]
19. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.
Mérino D; Lalaoui N; Morizot A; Schneider P; Solary E; Micheau O
Mol Cell Biol; 2006 Oct; 26(19):7046-55. PubMed ID: 16980609
[TBL] [Abstract][Full Text] [Related]
20. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
Yang J; Li G; Zhang K
Biomed Pharmacother; 2016 Dec; 84():1078-1087. PubMed ID: 27780136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
